|
UTP18 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.082000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.980800E-01 |
| Normal-vs-Stage2 |
7.850800E-01 |
| Normal-vs-Stage3 |
6.661400E-01 |
| Normal-vs-Stage4 |
6.651000E-01 |
| Stage1-vs-Stage2 |
8.205400E-01 |
| Stage1-vs-Stage3 |
5.586000E-01 |
| Stage1-vs-Stage4 |
6.132800E-01 |
| Stage2-vs-Stage3 |
5.653000E-01 |
| Stage2-vs-Stage4 |
5.752200E-01 |
| Stage3-vs-Stage4 |
9.610800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.614200E-01 |
| Normal-vs-AfricanAmerican |
9.151400E-01 |
| Normal-vs-Asian |
9.699800E-01 |
| Caucasian-vs-AfricanAmerican |
9.635800E-01 |
| Caucasian-vs-Asian |
8.132800E-01 |
| AfricanAmerican-vs-Asian |
9.070200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.130010E-01 |
| Normal-vs-Female |
3.857600E-01 |
| Male-vs-Female |
8.279200E-03 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.257600E-01 |
| Normal-vs-Age(41-60Yrs) |
6.319400E-01 |
| Normal-vs-Age(61-80Yrs) |
6.387000E-01 |
| Normal-vs-Age(81-100Yrs) |
3.120600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.015000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.083600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.706600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.649200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.096600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.355800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.234400E-01 |
| Classical-VS-Follicular |
8.97529999988045E-07 |
| Classical-VS-Other |
1.479000E-01 |
| Classical-VS-Normal |
1.156590E-01 |
| Tall-VS-Follicular |
1.938950E-03 |
| Tall-VS-Other |
1.587980E-01 |
| Tall-VS-Normal |
2.592600E-01 |
| Follicular-VS-Other |
8.666600E-01 |
| Follicular-VS-Normal |
5.019000E-03 |
| Other-VS-Normal |
4.818200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.449200E-01 |
| Normal-vs-N1 |
4.370800E-01 |
| N0-vs-N1 |
7.788600E-01 |
|
|
